Impact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial

Hdl Handle:
http://hdl.handle.net/10144/336635
Title:
Impact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial
Authors:
Cox, Helen S; Mbhele, Slindile; Mohess, Neisha; Whitelaw, Andrew; Muller, Odelia; Zemanay, Widaad; Little, Francesca; Azevedo, Virginia; Simpson, John; Boehme, Catharina C; Nicol, Mark P
Journal:
PLoS Medicine
Abstract:
Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in settings with high TB burden.
Publisher:
Public Library of Science
Issue Date:
25-Nov-2014
URI:
http://hdl.handle.net/10144/336635
DOI:
10.1371/journal.pmed.1001760
PubMed ID:
25423041
Language:
en
ISSN:
1549-1676
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorCox, Helen Sen_GB
dc.contributor.authorMbhele, Slindileen_GB
dc.contributor.authorMohess, Neishaen_GB
dc.contributor.authorWhitelaw, Andrewen_GB
dc.contributor.authorMuller, Odeliaen_GB
dc.contributor.authorZemanay, Widaaden_GB
dc.contributor.authorLittle, Francescaen_GB
dc.contributor.authorAzevedo, Virginiaen_GB
dc.contributor.authorSimpson, Johnen_GB
dc.contributor.authorBoehme, Catharina Cen_GB
dc.contributor.authorNicol, Mark Pen_GB
dc.date.accessioned2014-12-04T15:59:34Z-
dc.date.available2014-12-04T15:59:34Z-
dc.date.issued2014-11-25-
dc.identifier.citationImpact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial. 2014, 11 (11):e1001760 PLoS Med.en_GB
dc.identifier.issn1549-1676-
dc.identifier.pmid25423041-
dc.identifier.doi10.1371/journal.pmed.1001760-
dc.identifier.urihttp://hdl.handle.net/10144/336635-
dc.description.abstractXpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in settings with high TB burden.en_GB
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://medicine.plosjournals.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleImpact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trialen
dc.identifier.journalPLoS Medicineen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.